Health and Medicine

July 10, 2014

VU, Celgene announce research partnership

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.

By Bill Snyder
July 9, 2014

Study finds ‘hot’ frogs fight off fungal pathogen

Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature.

By Leigh MacMillan
July 7, 2014

Bringing Cancer to Light: Radiology’s invisible energies play lead role in cancer care

By Leigh MacMillan
June 26, 2014

Rousseau appointed to NIH study group

Vanderbilt researcher Bernard Rousseau, Ph.D., is being appointed to the Motor Function, Speech and Rehabilitation Study Section at the Center for Scientific Review, National Institutes of Health, for the term beginning July 1 and ending June 30, 2020.

By Craig Boerner
June 26, 2014

Aliyu receives alumnus award from UAB

Muktar Aliyu, M.D., MPH, Dr.P.H., associate director for Research at the Vanderbilt Institute for Global Health, is the recipient of the 2014 Alumnus Award for Scientific Excellence from the University of Alabama at Birmingham School of Public Health.

By Denise Anthony
kidney x-ray
June 26, 2014

VU study shows common diabetes drug can slow chronic kidney disease progression

Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes.

By Kathy Whitney
June 26, 2014

VUSM team seeks to hone in on health care ‘hot spots’

Vanderbilt University School of Medicine is fielding one of 10 teams of students selected to participate in a project aimed at identifying the most frequent users of health care.
By Jessica Pasley
June 19, 2014

HPV-positive head and neck cancer patients may receive lower radiation dose

A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects.
By VUMC News and Communications
June 19, 2014

Meharry-Vanderbilt Alliance awards grants to support community engagement in celebration of its 15-year anniversary

The Meharry-Vanderbilt Alliance is awarding grants to support activities that promote ongoing, mutually beneficial, health research partnerships between community organizations and academic researchers.
By VUMC News and Communications
June 19, 2014

VICC researchers in spotlight at national cancer conference

New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations.
By VUMC News and Communications
June 16, 2014

Factor impacts bone toughness

The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets.
By Leigh MacMillan
June 13, 2014

How ABC transporters move molecules

New views of how transporters move molecules across cell membranes are key to understanding how these proteins impact tumor cell drug resistance and inherited diseases such as cystic fibrosis.
By Leigh MacMillan
June 12, 2014

Study tracks insulin’s risks as second-line diabetes medication

In an observational study by researchers at Vanderbilt University Medical Center, adults with type 2 diabetes who take insulin in addition to the recommended first-line drug therapy, metformin, had a 30 percent higher risk of heart attack, stroke or death when compared to similar patients who instead augment their metformin regimen with a sulfonylurea.
By Paul Govern
1 … 139 140 141 142 143 … 197